Biologically Based Methods for Cancer Risk Assessment: NATO Science Series A:, cartea 159
Editat de Curtis Travisen Limba Engleză Paperback – 30 apr 2013
Din seria NATO Science Series A:
- 15% Preț: 651.74 lei
- 15% Preț: 650.31 lei
- 15% Preț: 673.35 lei
- Preț: 394.46 lei
- 5% Preț: 375.10 lei
- Preț: 394.84 lei
- 18% Preț: 1223.30 lei
- 5% Preț: 726.25 lei
- Preț: 410.13 lei
- 15% Preț: 644.44 lei
- 5% Preț: 366.74 lei
- Preț: 404.58 lei
- 5% Preț: 2146.20 lei
- Preț: 404.40 lei
- Preț: 393.50 lei
- 15% Preț: 659.04 lei
- Preț: 384.53 lei
- Preț: 390.26 lei
- Preț: 395.43 lei
- Preț: 398.30 lei
- 15% Preț: 673.83 lei
- Preț: 392.20 lei
- 18% Preț: 945.38 lei
- 15% Preț: 649.62 lei
- Preț: 399.05 lei
- Preț: 398.30 lei
- 15% Preț: 650.45 lei
- Preț: 391.82 lei
- Preț: 381.66 lei
- 5% Preț: 392.72 lei
- 5% Preț: 1411.08 lei
- 15% Preț: 646.56 lei
- Preț: 397.17 lei
- Preț: 384.14 lei
- 5% Preț: 383.26 lei
- Preț: 400.94 lei
- 15% Preț: 646.74 lei
- Preț: 391.01 lei
- 5% Preț: 373.66 lei
- Preț: 397.33 lei
- 5% Preț: 385.98 lei
- Preț: 397.71 lei
- 5% Preț: 735.13 lei
- 18% Preț: 1216.12 lei
- 5% Preț: 383.62 lei
- Preț: 418.72 lei
Preț: 374.75 lei
Preț vechi: 394.46 lei
-5% Nou
Puncte Express: 562
Preț estimativ în valută:
71.77€ • 73.95$ • 60.12£
71.77€ • 73.95$ • 60.12£
Carte tipărită la comandă
Livrare economică 24 februarie-10 martie
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9781468456271
ISBN-10: 146845627X
Pagini: 368
Ilustrații: IX, 355 p. 54 illus.
Dimensiuni: 178 x 254 x 19 mm
Greutate: 0.64 kg
Ediția:Softcover reprint of the original 1st ed. 1989
Editura: Springer Us
Colecția Springer
Seria NATO Science Series A:
Locul publicării:New York, NY, United States
ISBN-10: 146845627X
Pagini: 368
Ilustrații: IX, 355 p. 54 illus.
Dimensiuni: 178 x 254 x 19 mm
Greutate: 0.64 kg
Ediția:Softcover reprint of the original 1st ed. 1989
Editura: Springer Us
Colecția Springer
Seria NATO Science Series A:
Locul publicării:New York, NY, United States
Public țintă
ResearchCuprins
Research Needs for Biologically Based Risk Assessment.- Biological Bases for Cancer Models.- Multistage Models for Cancer Risk Assessment.- Understanding Multi-Stage Carcinogenesis at the Molecular Level: Notes on Recent Progress.- The Use of Enzyme-Altered Foci for Risk Assessment of Hepatocarcinogens.- Pathogenic Interrelationship of Focal Lesions, Nodules, Adenomas and Carcinomas in the Multistage Evolution of Azaserine-Induced Rat Pancreas Carcinogenesis.- Phenotypic Cellular Changes in Multistage Carcinogenesis.- Interspecies Extrapolation of Pharmacokinetics.- Interspecies Extrapolation.- Comparative Carcinogenesis: Is There a Theoretical Approach to Inter-Species Similarity.- Biological Basis for Interspecies Extrapolations of Halogenated Solvents and of 1,3-Butadiene.- Species-Specific Inhalation Pharmacokinetics of 2-Nitropropane, Methyl Ethyl Ketone, and n-Hexane.- Promotion as a Factor in Carcinogenesis.- Overview of Promotion as a Mechanism in Carcinogenesis.- Hepatocarcinogenesis by Non-Genotoxic Compounds.- The Role of Inhibited Intercellular Communication in Carcinogenesis: Implications for Risk Assessment From Exposure to Chemicals.- Comparative Analyses of the Timing and Magnitude of Genotoxic and Nongenotoxic Cellular Effects in Urinary Bladder Carcinogenesis.- Alterations in Gene Expression in Mouse Hepatocarcinogenesis.- Screening for Carcinogenesis.- Medium-Term Bioassay Models for Environmental Carcinogens — Two — Step Liver and Multi-Organ Carcinogenesis Protocols.- The Use of Aldh Induction as a Carcinogenic Risk Marker in Comparison With Typical in Vitro Mutagenicity System.- Expression of Inducible Cytochrome P-450 mRNAs During Promotion of Expermential Chemical Hepatocarcinogenesis.- An In Vitro Approach for Interspecies ExtrapolationUsing Animal and Human Airway Epithelial Cell Culture.- Cancer Risk Assessment.- Assement of Low-Exposure Risk from Carcinogens: Implications of the Knudson-Moolgavkar Two-Critical Mutation Theory.- A Biological Data Base for Methylene Chloride Risk Assessment.- Computer Simulation of Chemical Carcinogenesis.- Determination of Carcinogen Exposure by Immunological Techniques.- Risk Estimation for Leukemogenic Drugs.- Contributors.